LGND · Forms 3, 4, 5
Insider trades at LIGAND PHARMACEUTICALS INC
1 insider sold $1.5M of LIGAND PHARMACEUTICALS INC stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for LIGAND PHARMACEUTICALS INC (LGND) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Andrew Reardon | CLO & Secretary | Option exercise | 340 | $52.27 | $18K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 833 | $302.51 | $252K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 1,976 | $303.54 | $600K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 1,535 | $304.52 | $467K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 404 | $306.18 | $124K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 235 | $307.19 | $72K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 17 | $307.74 | $5K | Form 4 | |
| Martine Zimmermann | Director | Tax withholding | 115 | $298.50 | $34K | Form 4 | |
| Martine Zimmermann | Director | Sell | 1,200 | $285.00 | $342K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 300 | $283.99 | $85K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 1,800 | $285.17 | $513K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 2,115 | $286.36 | $606K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 385 | $287.53 | $111K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 400 | $288.98 | $116K | Form 4 | |
| Octavio Espinoza | Chief Financial Officer | Option exercise | 16,179 | $52.84 | $855K | Form 4 | |
| Octavio Espinoza | Chief Financial Officer | Option exercise | 2,074 | $70.04 | $145K | Form 4 | |
| Octavio Espinoza | Chief Financial Officer | Option exercise | 2,869 | $55.75 | $160K | Form 4 | |
| Octavio Espinoza | Chief Financial Officer | Option exercise | 7,171 | $57.22 | $410K | Form 4 | |
| Octavio Espinoza | Chief Financial Officer | Option exercise | 3,348 | $68.74 | $230K | Form 4 | |
| Octavio Espinoza | Chief Financial Officer | Sell (10b5-1 plan) | 31,641 | $292.07 | $9.2M | Form 4 | |
| Jason Haas | Director | Option exercise | 6,138 | $51.56 | $316K | Form 4 | |
| Jason Haas | Director | Sell | 7,138 | $292.81 | $2.1M | Form 4 | |
| Andrew Reardon | CLO & Secretary | Option exercise | 5,000 | $52.27 | $261K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 105 | $284.14 | $30K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 33 | $284.55 | $9K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 157 | $285.74 | $45K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 1,032 | $286.80 | $296K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 1,214 | $287.77 | $349K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 356 | $288.75 | $103K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 503 | $289.80 | $146K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 200 | $290.60 | $58K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 991 | $291.71 | $289K | Form 4 | |
| Andrew Reardon | CLO & Secretary | Sell (10b5-1 plan) | 409 | $292.82 | $120K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.